Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study

被引:0
作者
A Lustman
S Nakar
A D Cohen
S Vinker
机构
[1] Tel Aviv University,Department of Family Medicine
[2] Central District Clalit Health Services,Department of Family Medicine
[3] Chief Physician Office,undefined
[4] Clalit Health Services Headquarters,undefined
[5] Siaal Research Center for Family Medicine and Primary Care,undefined
[6] Faculty of Health Sciences,undefined
[7] Ben-Gurion University,undefined
来源
Prostate Cancer and Prostatic Diseases | 2014年 / 17卷
关键词
hydrophobic statins; hydrophilic statins; prevalence;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6 / 9
页数:3
相关论文
共 123 条
[1]  
Jemal A(2008)Cancer statistics CA Cancer J Clin 58 71-96
[2]  
Siegel R(2002)HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 508-519
[3]  
Ward E(2002)3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation Atherosclerosis 161 17-26
[4]  
Hao Y(2003)The statins as anticancer agents Clin Cancer Res 9 10-19
[5]  
Xu J(2008)Statins and prostate cancer prevention: where are we now and future directions Nat Clin Pract Urol 5 376-387
[6]  
Murray T(2008)Statin use and risk of prostate cancer: results from a population-based epidemiologic study Am J Epidemiol 168 250-260
[7]  
Wong WW(2007)Cholesterol-lowering drugs and prostate cancer risk: a population-based case–control study Cancer Epidemiol Biomarkers Prev 16 2226-2232
[8]  
Dimitroulakos J(2007)Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort Cancer Epidemiol Biomarkers Prev 16 2213-2217
[9]  
Minden MD(2000)3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case–control study Arch Intern Med 160 2363-2368
[10]  
Penn LZ(2010)Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database BMJ 340 c2197-1825